Intas Pharmaceuticals Limited Fluoxetine Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Fluoxetine Export Records India — #2 Exporter, 97 Shipments, $4.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Fluoxetine

India Pharmaceutical Trade Intelligence

$235.3M253 Suppliers101 CountriesHS 30049099

ExportsIndia → UNITED STATES65.6%India → CANADA12.9%

ImportsUNITED KINGDOM → India$6.7B GERMANY → India$738.6K

#1 Supplier: SIDMAK LABORATORIES

Intas Pharmaceuticals Limited — Fluoxetine Exporter #2 | $4.8M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Fluoxetine Exporter Profile

Indian Pharmaceutical Exporter · #2 for Fluoxetine · $4.8M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #2 Indian exporter of Fluoxetine with $4.8M in export value and 97 verified shipments. Intas Pharmaceuticals Limited holds a 2.1% market share in Fluoxetine exports across 7 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Fluoxetine Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Fluoxetine export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Fluoxetine?

Country	Value	Shipments	Share
CANADA	$1.9M	72	89.9%
NETHERLANDS	$191.4K	13	9.0%
MAURITIUS	$15.2K	2	0.7%
ZAMBIA	$4.5K	1	0.2%
ITALY	$1.3K

Who Are the Top Buyers of Fluoxetine from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
ACCORD HEALTHCARE INC.	CANADA	$403.7K	15
ACCORD HEALTHCARE INC.,	CANADA	$403.5K	12
ACCORD HEALTHCARE INC	CANADA	$322.0K	15
JAMP PHARMA CORPORATION	CANADA	$319.3K	13
ACCORD HEALTHCARE INC,	CANADA	$200.0K	4
BROCACEF NL : HUB	NETHERLANDS	$88.0K	3
MANTRA DISTRIBUTIONS INC	CANADA	$75.2K	4
BROCACEF NL:HUB	NETHERLANDS	$66.3K	2
BIOMEDPHARMA	CANADA	$66.3K	2
BIOMED PHARMA	CANADA	$41.7K	1

Intas Pharmaceuticals Limited supplies Fluoxetine to 23 buyers globally. The largest buyer is ACCORD HEALTHCARE INC. (CANADA), followed by ACCORD HEALTHCARE INC., (CANADA) and ACCORD HEALTHCARE INC (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Fluoxetine Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMACEUTICAL DRUGS AND MEDICINE PRACH-FLUOXETINE 20 EACH HARD GELATIN CAPSULECONTAINS FLUOXETINE HYDROCHLORIDE PH.	$200.0K	4
PHARMA DRUGS AND MEDI JAMP-FLUOXETINE CAPSULES 20MG AS PER INV	$170.5K	4
PH.DRU.& MED.: ACH FLUOXETINE 20MG CAPSU	$130.5K	3
PHARMA DRUGS & MEDI: FLUOXETINE CAPSULES	$119.5K	4
PH.DRU.& MED.: FLUOXETINE CAPSULES BP 20	$102.5K	3
PHARMA DRUGS & MEDI Fluoxetine Accord 20	$88.0K	3
PH.DRU.& MED.: FLUOXETINE CAPSULES BP 10	$87.0K	4
PHARMA DRUGS & MEDI: ACH FLUOXETINE 20MG	$80.8K	2
PHARMA DURGS AND MEDI JAMP-FLUOXETINE CA	$73.1K	4
PHARMA DRUG&MED:Fluoxetine Accord 20mg E	$66.3K	2

Intas Pharmaceuticals Limited exports 54 distinct Fluoxetine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICAL DRUGS AND MEDICINE PRACH-FLUOXETINE 20 EACH H with 4 shipments worth $200.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Fluoxetine Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
7	MARKSANS PHARMA LIMITED	$5.6M	168	3	$33.3K
1	SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED	$5.0M	99	1	$50.0K
2	INTAS PHARMACEUTICALS LIMITED ★	$4.8M	97	7	$50.0K
8	DR.REDDY'S LABORATORIES LTD	$4.7M	172	7	$27.3K
9	APL HEALTHCARE LIMITED	$3.6M	73	1	$48.9K

Intas Pharmaceuticals Limited ranks #2 among 253 Indian Fluoxetine exporters. Average shipment value of $50.0K compared to the market average of $233.1K. The closest competitors by value are MARKSANS PHARMA LIMITED and SIDMAK LABORATORIES (INDIA) PRIVATE LIMITED.

Which Indian Ports Ship Fluoxetine Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	603	16.3%
SAHAR AIR	508	13.7%
NHAVA SHEVA SEA (INNSA1)	285	7.7%
MUNDRA SEA	150	4.1%
MUNDRA SEA (INMUN1)	129	3.5%
Bombay Air	119	3.2%
DELHI AIR	110	3.0%
HYDERABAD ICD (INSNF6)	108	2.9%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Fluoxetine Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Fluoxetine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 108 individual customs records matching Intas Pharmaceuticals Limited exporting Fluoxetine, covering 54 formulations to 7 countries via 23 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 101+ countries, 522+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Fluoxetine

Fluoxetine

Intas Pharmaceuticals Limited — Fluoxetine Exporter Profile

Intas Pharmaceuticals Limited — Fluoxetine Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Fluoxetine?

Who Are the Top Buyers of Fluoxetine from Intas Pharmaceuticals Limited?

What Is India's Total Fluoxetine Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Fluoxetine Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Fluoxetine Exporters?

What Fluoxetine Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Fluoxetine to Key Markets

Canada — HC

How Does Intas Pharmaceuticals Limited Compare to Nearest Fluoxetine Exporters?

Which Indian Ports Ship Fluoxetine Exports?

What Other CNS & Psychiatric Products Does Intas Pharmaceuticals Limited Export?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Fluoxetine Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Fluoxetine Export Data from Intas Pharmaceuticals Limited

Fluoxetine Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source